SEC Form 4 · accession 0000899243-19-001955
Solid Biosciences Inc. · SLDB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pedro Alvaro Amorrortu
Officer — Chief Operating Officer
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001707502
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $22.93 | Jan 23, 2019 | A | 60,000 | A | — | Jan 23, 2029 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1This option was granted on January 23, 2019 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.